Evidence map›Paper›PMID 32693206›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2020

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data.

Désirée Erlinda Larenas-Linnemann, Tolly Epstein, Punita Ponda, David Bernstein, Paul Williams, Peter Creticos

Abstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Allergy and Immunotherapy During the Pandemic.Current otorhinolaryngology reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Désirée Erlinda Larenas-LinnemannResearch department, Medica Sur Clinical Foundation and Hospital, Mexico city, Mexico. Electronic address: clinicadealergiayasma@yahoo.com.mx.
Tolly EpsteinDivision of Immunology, Allergy, and Rheumatology, Department of Internal Medicine, University of Cincinnati School of Medicine, Cincinnati, Ohio; Allergy Partners of Central Indiana, Indianapolis, Indiana.
Punita PondaDepartment of Medicine and Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
David BernsteinDivision of Immunology, Allergy, and Rheumatology, Department of Internal Medicine, University of Cincinnati School of Medicine, Cincinnati, Ohio.
Paul WilliamsDivision of Allergy/Inflammation, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; Northwest Asthma and Allergy Center, Everett, Washington.
Peter CreticosDivision of Allergy and Clinical Immunology, Johns Hopkins Medicine, Baltimore, Maryland; Creticos Research Group, LLC, Crownsville, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient ComplianceAllergensCOVID-19Desensitization, ImmunologicHumansInjections, SubcutaneousAllergens

Identifiers

PMID32693206
PMCPMC7368643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.